Summary
Chromatin from myeloma cells RPC 5 and ABPC 22, and from spleen and liver cells of immunized rats and mice, and mice bearing tumours, was fractionated into three parts: 0.35 M NaCl-soluble, 2 M NaCl-soluble and residual. The residual fraction from myeloma cells differed from that of immunized spleen cells, described previously as containing unique sequences (5), in that it has higher protein and DNA levels, lower DNase II sensitivity and lower template activity.
Similar content being viewed by others
References
Rakowicz-Szulezyńska, E. M. and Horst, A., 1978. Acta Biochim. Polon. 25: 221–227.
Horst, A., Rakowicz-Szulezyńska, E. M. and Wiland, E., 1981. Mol. Cell. Biochem. 37: 3–12.
Rakowicz-Szulezyńska, E. M. and Horst, A., 1981. Mol. Cell. Biochem. 37: 13–19.
Horst, A. and Rakowicz-Szulezyńska, E. M., 1981. Mol. Cell. Biochem. 37: 21–25.
Rakowicz-Szulezyńska, E. M. and Horst, A., 1981. Biochim. Biophys. Acta 653: 69–82.
Rakowicz-Szulezńska, E. M. and Horst, A. Mot. Cell. Biochem. in press.
Rakowicz-Szulezyńska, E. M. and Horst, A., 1979. Bull. Acad. Polon. Sci. Ser. Sci. Biol. 27: 823–826.
Rakowicz-Szulezyńska, E. M. and Horst, A., 1980. Mol. Cell. Biochem. 33: 115–119.
Rakowicz-Szulezyńska, E. M., 1979. Acta Anthropogenetica 3: 45–50.
Marushige, K. and Bonner, J., 1966. J. Mol. Biol. 15: 160–174.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L. and Randal, R. J., 1951. J. Biol. Chem. 193: 265–275.
Burton, K., 1956. Biochem. J. 62: 315–323.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rakowicz-Szulczyńska, E.M., Horst, A. Differences in salt solubility, DNase II sensitivity and template activity of chromatin from antibody synthesizing spleen cells and myeloma cells RPC 5 and ABPC 22. Mol Cell Biochem 48, 71–76 (1982). https://doi.org/10.1007/BF00227607
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00227607